During the past decade, Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2 conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 15 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2" #1 collaborator was "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2" are "Bladder Cancer" (3 trials), "Kidney Neoplasms" (2 trials), "Malignant Melanoma" (2 trials), "Prostate Cancer" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2" in a lesser frequency.

Most popular intervention types in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2" are "Drug" (23 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (11 trials), "Placebo" (5 trials), "Cisplatin" (3 trials), "Abiraterone" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2" are 21 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".